The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kita, H.
Right arrow Articles by Gleich, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kita, H.
Right arrow Articles by Gleich, G. J.
The Journal of Immunology, 1999, 162: 6901-6911.
Copyright © 1999 by The American Association of Immunologists

Does IgE Bind to and Activate Eosinophils from Patients with Allergy?1

Hirohito Kita2, Masayuki Kaneko, Kathleen R. Bartemes, Deborah A. Weiler, Andrew W. Schimming, Charles E. Reed and Gerald J. Gleich

Departments of Immunology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905

Human eosinophils have been reported to express both the mRNA and protein for the high affinity IgE receptor (Fc{epsilon}RI); it is speculated that this receptor plays a role in eosinophil mediator release in allergic diseases. However, questions still remain. How much of the Fc{epsilon}RI protein is actually expressed on the cell surface of the eosinophil? If they are present, are these IgE receptors associated with effector functions of eosinophils? To address these issues, we studied blood eosinophils from patients with ragweed hay fever. A high level of low affinity IgG receptor (Fc{gamma}RII, CD32), but no expression of Fc{epsilon}RI, was detectable on the eosinophil surface by standard FACS analysis. However, after in vitro sensitization with biotinylated chimeric IgE (cIgE), cell-bound cIgE was detected by PE-conjugated streptavidin. This cIgE binding was partially inhibited by anti-Fc{epsilon}RI mAb, suggesting that eosinophils do express minimal amounts of Fc{epsilon}RI detectable only by a sensitive method. Indeed, FACS analysis of whole blood showed that eosinophils express ~0.5% of the Fc{epsilon}RI that basophils express. When stimulated with human IgE or anti-human IgE, these eosinophils did not exert effector functions; there was neither production of leukotriene C4 or superoxide anion nor any detectable degranulation response. In contrast, eosinophils possessed membrane-bound human IgG and showed functional responses when stimulated with human IgG or anti-human IgG. Thus, IgG and/or cytokines, such as IL-5, appear to be more important for eosinophil activation in allergic diseases than IgE.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. B. Sundstrom, G. A. Hair, A. A. Ansari, W. E. Secor, A. M. Gilfillan, D. D. Metcalfe, and A. S. Kirshenbaum
IgE-Fc{epsilon}RI Interactions Determine HIV Coreceptor Usage and Susceptibility to Infection during Ontogeny of Mast Cells
J. Immunol., May 15, 2009; 182(10): 6401 - 6409.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Monteseirin, A. Vega, P. Chacon, M. J. Camacho, R. El Bekay, J. A. Asturias, A. Martinez, P. Guardia, R. Perez-Cano, and J. Conde
Neutrophils as a Novel Source of Eosinophil Cationic Protein in IgE-Mediated Processes
J. Immunol., August 15, 2007; 179(4): 2634 - 2641.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. M. Ganley-Leal, P. N. Mwinzi, C. B. Cetre-Sossah, J. Andove, A. W. Hightower, D. M. S. Karanja, D. G. Colley, and W. E. Secor
Correlation between Eosinophils and Protection against Reinfection with Schistosoma mansoni and the Effect of Human Immunodeficiency Virus Type 1 Coinfection in Humans
Infect. Immun., April 1, 2006; 74(4): 2169 - 2176.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. Ferrari, A. la Sala, E. Panther, J. Norgauer, F. Di Virgilio, and M. Idzko
Activation of human eosinophils via P2 receptors: novel findings and future perspectives
J. Leukoc. Biol., January 1, 2006; 79(1): 7 - 15.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Inoue, Y. Matsuwaki, S.-H. Shin, J. U. Ponikau, and H. Kita
Nonpathogenic, Environmental Fungi Induce Activation and Degranulation of Human Eosinophils
J. Immunol., October 15, 2005; 175(8): 5439 - 5447.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Belostotsky and H. Lorberboum-Galski
Apoptosis-Inducing Human-Origin Fc{epsilon}-Bak Chimeric Proteins for Targeted Elimination of Mast Cells and Basophils: A New Approach for Allergy Treatment
J. Immunol., October 15, 2001; 167(8): 4719 - 4728.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Kayaba, D. Dombrowicz, G. Woerly, J.-P. Papin, S. Loiseau, and M. Capron
Human Eosinophils and Human High Affinity IgE Receptor Transgenic Mouse Eosinophils Express Low Levels of High Affinity IgE Receptor, but Release IL-10 upon Receptor Activation
J. Immunol., July 15, 2001; 167(2): 995 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Bheekha-Escura, D. W. MacGlashan Jr, J. M. Langdon, and S. M. MacDonald
Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10
Blood, September 15, 2000; 96(6): 2191 - 2198.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.